St. John's University College of Pharmacy and Health Sciences

Are you interested?

featured image
Private (proprietary)
Graduate Programs
Total Full-Time Tuition
varies by program
Graduate Students

« Back to Search

An Inside Look

Since its founding in 1929, the College of Pharmacy and Health Sciences at St. John’s University has trained scholars and practitioners who are respected for the quality oftheir contributions and compassion for those they serve. 

Profile Image


Doctor of Philosophy
• Pharmaceutical Sciences
- Medicinal Chemistry
- Pharmacology
- Pharmacy
- Toxicology

Master of Science
• Pharmaceutical Sciences
- Industrial Pharmacy
- Medicinal Chemistry
- Pharmacology
• Pharmacy Administration
- Drug Regulatory Affairs/Quality
- Pharmaceutical Marketing

• Physician Assistant
• Toxicology

Master of Public Health
• The MPH degree is a 45-credit professional degree that focuses on the core competencies of public health and concludes with an applied fieldwork practice experience and culminating experience. Concentrations include Community Health or Global Health.

Collaborative Master of Science
• Biological and Pharmaceutical Biotechnology
- Available through the University’s
Institute of Biotechnology, a collaborative program with the College of Pharmacy and Health Sciences and St. John’s College of Liberal Arts and Sciences

Advanced degree programs within the College rely on original research and discoverythrough rigorous scientific investigation in order to advance our understanding of the world.

Student centered and outcomes oriented, these graduate programs offer preparation for careers in the pharmaceutical industry, the health fields, and academia. Programs draw upon the expertise of internationally recognized faculty who specialize in designing and developing new therapeutic agents and tools, evaluating the physiological effects of drugs, and investigating the biological bases of disease.

Stellar education and prime location lead to tremendous outcomes

St. John’s University has an alumni network of more than 183,000—more than 80% of whom reside in the New York metropolitan area. These contacts in a hub of international biomedical, health care, and pharmaceutical industries lead to impressive outcomes for students.

Recent graduates from the College’s global student population are currentlyworking for Avon, the Environmental Protection Agency, Estee Lauder, the National Institutes of Health (NIH), Novartis, Pfizer, Regeneron Pharmaceuticals, and the US Food and Drug Administration (FDA) as well as elitemedical schools across the country. Increasingly, St. John’s international graduates return to their home countries to assume research and leadership roles in these growing industries.

Evolving technologies
In 2018, the College of Pharmacy and Health Sciences announced the acquisition of the new Anatomage virtual dissection tables at the University’s Queens campus and Dr. Andrew J. Bartilucci Center. The Anatomage is the world’s first and most technologically advanced virtual dissection table for anatomy education, and it can effectively replace expensive and cumbersome cadaver laboratories.

The ultramodern laboratories and research facilities within St. Albert Hall on the Queens campus also include numerous other state-of-the-art technologies and instrumentation that include gas chromatograph/mass spectrometers, inductively coupled plasma atomic emission spectrometers, tissue culture labs, real-time polymerase chain reaction instruments, dissolution instruments, hot melt extruders,thermal gravilometric analyzers, particle size analyzers, and analytical scanning and transmission electron microscopes.

Research is key
Grants for the College have amassed over the years. Most recently, Vivek Gupta, PhD, Assistant Professor, obtained two grants from the American Heart Association (AHA) and the NIH totaling more than $600,000 for his research in treating pulmonary hypertension.

The AHA grant will screen drugs already approved by the FDA against cells isolated from patients who suffer from the disease and observe the drugs’ impact on pulmonary hypertension symptoms. Instead of a 15–20-year process, Dr. Gupta said the potential exists for it to take only two to three years to reach the market. The drugs will be screened using robotics, which could reduce the cost by 60%–70%. The grant is for two years, and funding is for $154,000.

The NIH grant is derived from research Dr. Gupta already conducted regarding the antimalarial drug Amodiaquine to treat pulmonary hypertension. Dr. Gupta said he will be able to conduct pre-clinical trials to test its efficacy. The hope is that it will reverse the effects of the condition. The grant is for three years and totals $492,000.

Are you interested?

Yes, connect me!

6 Graduate Programs Offered

Program Certificate Master's Doctorate
Campus Hybrid Online Campus Hybrid Online Campus Hybrid Online
Pharmaceutical Science              
Pharmacy Administration                
Physician Assistant                
Public Health                


CollegeXpress Logo


Are you our next winner?

Register now for our scholarship giveaway

Not reported


Application Fee
*may vary by program
Housing Offered? None


Admissions Office
P: 719 990-2000